Category Archives: TB

WHO’s HIV/TB update latest move toward treatment as prevention

By on .

The potential for antiretroviral medicine to reduce transmission of HIV and tuberculosis has been demonstrated, but the challenges of using treatment to prevent infection will need to be tackled country by country, and with focus on people for whom it will have the biggest impact, the latest bulletin on HIV treatment from the World Health […]

Global Fund changes highlight opportunities, challenges

By on .

The Kaiser Family Foundation’s panel talk on changes at The Global Fund to Fight AIDS, Tuberculosis and Malaria, focused on the impact of reorganization at the charity at a time when scientific progress offers unprecedented chances for inroads against the diseases. Panelists Joanne Carter, executive director of RESULTS/RESULTS EDUCATION FUND, J. Stephen Morrison, senior vice […]

Global Fund countries respond to realities, make more of their money

By on .

Facing uncertain future funding, countries receiving grants from the Global Fund to Fight AIDS, Tuberculosis, and Malaria have used what they know about their own epidemics to redirect money to programs where it will have its greatest impact, the latest edition of Aidspan’s Global Fund Observer reports. The Fund has encouraged the effort during renewal […]

Breaking News: Senate subcommittee votes to boost funding for Global Fund and global TB in 2013

By on .

The Senate Appropriations Subcommittee on State and Foreign Operations voted Tuesday on its funding bill for global health and foreign assistance programs beginning Oct. 1, 2012.  The committee voted to fund the Global Fund to fight AIDS, Tuberculosis and Malaria at the president’s budget request of $1.65 billion – which would fulfill the U.S. four-year, […]

Breaking News: House committee approves 2013 funding for PEPFAR, Global Fund, global TB

By on .

The House Appropriations Committee voted on its fiscal year (FY) 2013 State and Foreign Operations Appropriations bill Wednesday and released a report that clarifies its funding intentions for key global health programs.  The bill includes $5.542 billion for global AIDS funding through the State Department, and the report specifies $4.243 billion to support the U.S. […]

UN: World will fall short of ambitious 2015 HIV/AIDS goals

By on .

The United Nations (UN) General Assembly gave some bad news Monday – the 2015 global HIV/AIDS targets will not be met unless there is significant scale up in several areas. The targets were set by the 2011 Political Declaration on HIV and AIDS: Intensifying our Efforts to Eliminate HIV and AIDS. The declaration was adopted […]

Antiretroviral therapy as prevention: TB

By on .

Stephen Lawn reminded the audience at the International Treatment as Prevention Workshop in Vancouver on Wednesday that antiretroviral therapy (ART) goes a long way to protect HIV-infected individuals from tuberculosis (TB). The HIV-associated TB epidemic requires “radical interventions,” according to Lawn.  “DOTS [directly observed TB therapy, short course] just isn’t doing it.” He called the […]

Breaking: World Bank selects Dr. Jim Kim as next president

By on .

Jim Yong Kim MD, PhD (Photo Courtesy: National Institutes of Health) The Executive Directors of the World Bank met in Washington, DC, Monday – and announced their selection of Jim Kim, MD, PhD, as the 12th president of the poverty-reduction organization. Kim’s five-year term will start on July 1, when he succeeds current president Robert […]

NIH announces new $20 million initiative to train early career global health researchers

By on .

Global health researchers early on in their careers now have a new opportunity for mentored research in a developing country. The National Institutes of Health (NIH) announced Wednesday a new effort to award $20.3 million over the next five years to 400 physicians, veterinarians, dentists and scientists on nearly year-long fellowships at approximately 80 sites […]

Tackling TB/HIV co-infection in Africa: An interview with CDC’s Dr. Bess Miller

By on .

Science Speaks continues its interview series exploring the global HIV and tuberculosis research and development efforts at the U.S. Centers for Disease Control and Prevention (CDC) with a conversation with Bess Miller, MD, MSc, who works in the Division of Global HIV/AIDS. Dr. Miller has served as associate director and team lead for HIV/TB, providing leadership in policy and implementation of TB/HIV activities in 43 resource-limited countries supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). She has worked to align PEPFAR TB/HIV priorities with the World Health Organization (WHO) policies on TB/HIV, and on the use of antiretroviral therapy (ART) in people living with HIV (PLHIV). In this interview Dr. Miller discusses the successes and challenges in implementing TB infection control in Africa, progress in deploying the GeneXpert MTB/RIF rapid TB diagnostic on the ground there, and how efforts to scale up access to ART are helping achieve goals in TB control and elimination.